Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | -364 | 1,675 | 1,994 |
| Cost of Goods | N/A | N/A | 158 | 409 | 514 |
| Gross Profit | N/A | N/A | -522 | 1,266 | 1,480 |
| Operating Expenses | 1,349 | 1,503 | 4,674 | 6,481 | 4,457 |
| Operating Income | -1,349 | -1,503 | -5,039 | -4,807 | -2,463 |
| Interest Expense | 0 | 0 | 126 | 131 | 137 |
| Other Income | 1,733 | 1,886 | 5,483 | 389 | 53 |
| Pre-tax Income | 384 | 383 | 318 | -4,550 | -2,547 |
| Net Income Continuous | 384 | 383 | 318 | -4,550 | -2,547 |
| Net Income Discontinuous | -2,093 | -5,091 | N/A | N/A | N/A |
| Net Income | $-1,708 | $-4,708 | $318 | $-4,550 | $-2,547 |
| EPS Basic Total Ops | -9.25 | -42.19 | -41.00 | -71.25 | -30.00 |
| EPS Basic Continuous Ops | -5.71 | -28.81 | 6.53 | -53.68 | -30.06 |
| EPS Basic Discontinuous Ops | -3.54 | -13.38 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -9.25 | -42.19 | -41.00 | -71.25 | -30.00 |
| EPS Diluted Continuous Ops | -5.71 | -28.81 | 6.53 | -53.68 | -30.06 |
| EPS Diluted Discontinuous Ops | -3.54 | -13.38 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -9.25 | -51.25 | -54.25 | N/A | N/A |
| EBITDA(a) | $-1,349 | $-1,503 | $-4,201 | $-3,946 | $-1,604 |